Related references
Note: Only part of the references are listed.Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database
Harry E. Fuentes et al.
INTERNATIONAL ANGIOLOGY (2019)
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE)
Behnood Bikdeli et al.
THROMBOSIS AND HAEMOSTASIS (2018)
DVT Management and Outcome Trends, 2001 to 2014
Raquel Morillo et al.
CHEST (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Trends in the Management and Outcomes of Acute Pulmonary Embolism Analysis From the RIETE Registry
David Jimenez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2016)
Guideline on aspects of cancer-related venous thrombosis
Henry G. Watson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
Dominique Farge et al.
MEDICINE (2015)
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Isabelle Mahe et al.
PLOS ONE (2015)
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
Cheng E. Chee et al.
BLOOD (2014)
CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
Agnes Y. Y. Lee et al.
BMC CANCER (2013)
Venous thromboembolism and prognosis in cancer
Alok A. Khorana
THROMBOSIS RESEARCH (2010)
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism - Findings from the RIETE Registry
Javier Trujillo-Santos et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry
M. Monreal et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Share Paper
